市場調査レポート
商品コード
1410836
結核菌検査市場:市場規模(セグメント別)、シェア、規制、償還、予測(~2033年)Mycobacterium Tuberculosis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
結核菌検査市場:市場規模(セグメント別)、シェア、規制、償還、予測(~2033年) |
出版日: 2023年12月08日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
|
結核には潜伏結核と活動性結核の2つの感染様式があります。潜在性結核の場合、結核菌は体内で休眠状態にあります。大多数の人は症状を示しませんが、これらの患者は活動性結核感染を発症するリスクがあると考えられています。結核は、結核皮膚検査(TST)、インターフェロンγ放出測定法(IGRA)の血液検査、核酸増幅検査(NAAT)、喀痰塗抹顕微鏡検査、培養検査など、さまざまな検査で検出することができます。さらに、胸部X線検査も結核感染の診断によく用いられます。多剤耐性結核は、世界の結核撲滅にとってますます深刻な脅威となっています。検査インフラが一貫しておらず、検査専門医や臨床医が不足しているため、診断が困難です。MDR-TBは、結核菌が少なくともイソニアジドとリファンピシンに耐性であることと定義され、XDR-TBはフルオロキノロンを含むより多くの薬剤、および3種類の注射薬(アミカシン、カナマイシン、カプレオマイシン)のいずれかに耐性をもっています。
結核菌診断検査には、IGRA検査と結核菌NAAT検査があります。
当レポートは、世界の結核菌検査市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。
Not Applicable
Not Applicable
Mycobacterium Tuberculosis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on Mycobacterium Tuberculosis Tests market for the year 2020 and beyond. The tuberculosis (TB) infection has two modes of existence, latent TB and active TB. For latent TB, the mycobacterium is dormant within the body. The majority of individuals do not exhibit symptoms, but these patients are considered to be at risk for developing an active TB infection. Tuberculosis can be detected by a number of different tests including the tuberculosis skin test (TST), blood tests of interferon gamma release assays (IGRA), nucleic acid amplification tests (NAATs), sputum smear microscopy tests, and culture tests. Additionally, chest x-Rays are also often used to help diagnose TB infection. Multidrug-resistant tuberculosis is an increasingly serious threat to the eradication of global TB. Hard to diagnose due to the inconsistent testing infrastructure and lack of laboratory specialists and clinicians. MDR-TB is defined as the TB bacilli being resistant to at least isoniazid and rifampicin, while XDR-TB is resistant to more medicaments including fluoroquinolone, and to one of the three injectable drugs (amikacin, kanamycin, and capreomycin).
The Mycobacterium Tuberculosis diagnostic tests include IGRA and Mycobacterium Tuberculosis NAAT tests.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Mycobacterium Tuberculosis Tests and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Qiagen NV, Oxford Immunotec Ltd, Danaher Corp, Molbio Diagnostics Pvt Ltd, Hologic Inc, F. Hoffmann-La Roche Ltd, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable